Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
2,168.00
+28.00 (1.31%)
Jul 14, 2026, 3:30 PM JST
TYO:4538 Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
Net Income | 2,011 | - | - | 6,237 | 6 |
Depreciation & Amortization | 2,618 | - | - | 1,750 | 1,888 |
Loss (Gain) From Sale of Assets | - | - | - | -2,472 | 26 |
Loss (Gain) From Sale of Investments | -90 | - | - | 21 | - |
Other Operating Activities | -816 | - | - | -14 | -30 |
Change in Accounts Receivable | -405 | - | - | -3,170 | -401 |
Change in Inventory | -740 | - | - | -901 | -881 |
Change in Accounts Payable | -1,549 | - | - | 831 | 97 |
Change in Other Net Operating Assets | -7,253 | - | - | 976 | 179 |
Operating Cash Flow | -6,224 | - | - | 3,258 | 884 |
Operating Cash Flow Growth | - | - | - | 268.55% | -87.27% |
Capital Expenditures | -1,266 | - | - | -1,928 | -1,206 |
Sale of Property, Plant & Equipment | - | - | - | 3,975 | - |
Sale (Purchase) of Intangibles | -393 | - | - | - | - |
Investment in Securities | 261 | - | - | 635 | -105 |
Other Investing Activities | -117 | - | - | -266 | -71 |
Investing Cash Flow | -1,515 | - | - | 2,416 | -1,382 |
Short-Term Debt Issued | 8,000 | - | - | - | 295 |
Long-Term Debt Issued | - | - | - | 3,270 | 4,300 |
Total Debt Issued | 8,000 | - | - | 3,270 | 4,595 |
Short-Term Debt Repaid | - | - | - | -100 | - |
Long-Term Debt Repaid | -827 | - | - | -3,452 | -3,104 |
Total Debt Repaid | -827 | - | - | -3,552 | -3,104 |
Net Debt Issued (Repaid) | 7,173 | - | - | -282 | 1,491 |
Repurchase of Common Stock | -2 | - | - | -5 | -3 |
Common Dividends Paid | -734 | - | - | -542 | -542 |
Other Financing Activities | -116 | - | - | -3 | -3 |
Financing Cash Flow | 6,321 | - | - | -832 | 943 |
Foreign Exchange Rate Adjustments | - | - | - | - | -1 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 |
Net Cash Flow | -1,418 | - | - | 4,842 | 445 |
Free Cash Flow | -7,490 | - | - | 1,330 | -322 |
Free Cash Flow Margin | -12.02% | - | - | 2.74% | -0.73% |
Free Cash Flow Per Share | -877.19 | - | - | 146.90 | -35.56 |
Cash Interest Paid | 338 | - | - | 261 | 247 |
Cash Income Tax Paid | 1,342 | - | - | 17 | 44 |
Levered Free Cash Flow | 2,131 | - | - | 1,161 | -313.13 |
Unlevered Free Cash Flow | 2,336 | - | - | 1,326 | -149.38 |
Change in Working Capital | -9,947 | - | - | -2,264 | -1,006 |